Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Ernst

Showing results (41-50 of 172) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2013
Reply to Trezza et AlFrancesco Lapi, Pierre Ernst, Samy Suissa
Chest|October 21, 2005
Cardiovascular morbidity and mortality in COPDLaetitia Huiart, Pierre Ernst, Samy Suissa
Chest|August 10, 2020
ResponseSamy Suissa, Sophie Dell'Aniello, Pierre Ernst
COPD|September 21, 2021
Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on MortalitySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
COPD|April 6, 2022
Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and SafetySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
Archivos De Bronconeumologia|January 7, 2023
Beta-agonist Use and Increased Asthma Mortality: Reality or Fiction?Nan Zhao, Samy Suissa, Pierre Ernst
The Lancet. Respiratory Medicine|October 22, 2018
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort studySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
The European Respiratory Journal|December 25, 2014
Inhaled corticosteroids in COPD: the clinical evidencePierre Ernst, Nathalie Saad, Samy Suissa
Respiratory Medicine|November 10, 2021
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safetySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
Chest|October 26, 2024
Single-Inhaler Triple vs Long-Acting Beta<sub>2</sub>-Agonist-Inhaled Corticosteroid Therapy for COPD: Comparative Safety in Real-World Clinical PracticeSamy Suissa, Sophie Dell'Aniello, Pierre Ernst
Pageof 18

Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2013
Reply to Trezza et AlFrancesco Lapi, Pierre Ernst, Samy Suissa
Chest|October 21, 2005
Cardiovascular morbidity and mortality in COPDLaetitia Huiart, Pierre Ernst, Samy Suissa
Chest|August 10, 2020
ResponseSamy Suissa, Sophie Dell'Aniello, Pierre Ernst
COPD|September 21, 2021
Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on MortalitySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
COPD|April 6, 2022
Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and SafetySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
Archivos De Bronconeumologia|January 7, 2023
Beta-agonist Use and Increased Asthma Mortality: Reality or Fiction?Nan Zhao, Samy Suissa, Pierre Ernst
The Lancet. Respiratory Medicine|October 22, 2018
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort studySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
The European Respiratory Journal|December 25, 2014
Inhaled corticosteroids in COPD: the clinical evidencePierre Ernst, Nathalie Saad, Samy Suissa
Respiratory Medicine|November 10, 2021
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safetySamy Suissa, Sophie Dell'Aniello, Pierre Ernst
Chest|October 26, 2024
Single-Inhaler Triple vs Long-Acting Beta<sub>2</sub>-Agonist-Inhaled Corticosteroid Therapy for COPD: Comparative Safety in Real-World Clinical PracticeSamy Suissa, Sophie Dell'Aniello, Pierre Ernst
Pageof 18